Prevention of Human Lymphoproliferative Tumor Formation in Ovarian Cancer Patient-Derived Xenografts()()

Interest in preclinical drug development for ovarian cancer has stimulated development of patient-derived xenograft (PDX) or tumorgraft models. However, the unintended formation of human lymphoma in severe combined immunodeficiency (SCID) mice from Epstein-Barr virus (EBV)–infected human lymphocytes...

Descripción completa

Detalles Bibliográficos
Autores principales: Butler, Kristina A., Hou, Xiaonan, Becker, Marc A., Zanfagnin, Valentina, Enderica-Gonzalez, Sergio, Visscher, Daniel, Kalli, Kimberly R., Tienchaianada, Piyawan, Haluska, Paul, Weroha, S. John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2017
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5487305/
https://www.ncbi.nlm.nih.gov/pubmed/28658648
http://dx.doi.org/10.1016/j.neo.2017.04.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5487305/
https://www.ncbi.nlm.nih.gov/pubmed/28658648
http://dx.doi.org/10.1016/j.neo.2017.04.007

Ejemplares similares